AAPL 167.3 +3.34 (+2.04%)MSFT 104.11 +1.23 (+1.20%)FB 145.75 +5.44 (+3.88%)ZNGA 3.73 0 (+0.13%)NVDA 150.2 +6.7 (+4.67%)WBA 76.32 +0.25 (+0.34%)GOOG 1045.03 +27.51 (+2.70%)PIH 4.26 -0.74 (-14.80%)
AAPL 167.3 +3.34 (+2.04%)MSFT 104.11 +1.23 (+1.20%)FB 145.75 +5.44 (+3.88%)ZNGA 3.73 0 (+0.13%)NVDA 150.2 +6.7 (+4.67%)WBA 76.32 +0.25 (+0.34%)GOOG 1045.03 +27.51 (+2.70%)PIH 4.26 -0.74 (-14.80%)

Cash Flow ADMS Quote Adamas Phar

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
NetIncome -52 -60 -89
Depreciation 0 1 1
DeferredIncomeT 0 0 0
StockBasedCompe 10 11 13
AccountsReceiva -1 0 0
InventoryCS 0 0 -2
AccountsPayable -1 1 0
OtherWorkingCap 0 0 0
OtherNonCashIte 0 0 4
NetCashProvided -47 -48 -67
InvestmentsInPP -1 -2 -1
AcquisitionsNet 0 0 0
PurchasesOfInve -60 -104 -63
SalesMaturities 69 78 89
PurchasesOfInta 0 0 0
OtherInvestingA 0 0 0
NetCashUsedForI 8 -27 26
DebtIssued 0 0 100
DebtRepayment 0 0 0
CommonStockIssu 10 62 0
CommonStockRepu 0 0 0
DividendPaid 0 0 0
OtherFinancingA 1 4 9
NetCashProvided 11 65 109
NetChangeInCash -28 -9 68
CashAtBeginning 61 33 24
CashAtEndOfPeri 33 24 91
Adamas Pharmaceuticals Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Adamas Pharmaceuticals Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.